Kim's Eye Hospital
9 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Switching to Aflibercept 8mg in Patients Showing Limited Response to Previous Treatment (NCT06683950) | Kim's Eye Hospital | 2024-10-21 |
| Choroidal Morphology Changes After Aflibercept Therapy in Pachychoroid Neovasculopathy (NCT05662410) | Kim's Eye Hospital | 2022-12-26 |
| Outcomes of Tolerating Subretinal Fluid in Type 1 MNV and PCV (NCT05662943) | Kim's Eye Hospital | 2022-12-05 |
| Treat-and-extend Using Aflibercept for Type 3 Neovascularization (NCT04655482) | Kim's Eye Hospital | 2021-02-01 |
| Eyes That Do Not Meet the Eligibility Criteria of Clinical Trials on Age-Related Macular Degeneration: Proportion of the Real-World Patient Population and Reasons for Exclusion (NCT04836143) | Kim's Eye Hospital | 2019-08-26 |
Track Kim's Eye Hospital automatically
Every clearance here is in the API, with alerts when new ones post.